The clinical significance of c-myc oncogene expression in melanomas of the scalp

British Journal of Plastic Surgery

Volumn 51, Issue 3, 1998, Pages 191-194

  Chana, J S ^a   Grover, R ^a   Wilson, G D ^a   Hudson, D A ^b   Forders, M ^b   Sanders, R ^a   Grobbelaar, A O ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MALE; MELANOMA; ONCOGENE C MYC; PRIORITY JOURNAL; PROGNOSIS; SCALP TUMOR;

EID: 0032054549     PISSN: 00071226     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjps.1997.0233     Document Type: Article

References (21)

1. 1. Balch CM. Cutaneous melanoma: prognosis and treatment results worldwide. Semin Surg Oncol 1992; 8: 400-14.
2. 2. Thorn M, Adami HO, Ringborg U, Bergstrom R, Krusemo U. The association between anatomic site and survival in malignant melanoma. An analysis of 12,353 cases from the Swedish Cancer Registry. Eur J Cancer Clin Oncol 1989; 25: 483-91.
3. 3. Essner R, Wong JH, Economou JS, Morton DL. Prognostic significance of melanoma arising in the scalp. Am J Surg 1988; 156: 314-7.
4. 4. Wanebo HJ, Cooper PH, Young DV, Harpole DH, Kaiser DL. Prognostic factors in head and neck melanoma. Effect of lesion location. Cancer 1988; 62: 831-7.
5. 5. O'Brien CJ, Coates AS, Peterson-Schaefer K, et al. Experience with 998 cutaneous melanomas of the head and neck over 30 years. Am J Surg 1991; 162: 310-4.
6. 6. Hudson DA, Krige JE. Results of 3 cm excision margin for melanoma of the scalp. J R Coll Surg Edinb 1995; 40: 93-6.
7. 7. Evan GI, Littlewood TD. The role of c-myc in cell growth. Curr Opin Gen Dev 1993; 3: 44-9.
8. 8. Lu X, Park SH, Thompson TC, Lane DP. ras-induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation. Cell 1992; 70: 153-61.
9. 9. Riou GF. Proto-oncogenes and prognosis in early carcinoma of the uterine cervix. Cancer Surveys 1988; 7: 441-56.
10. 10. Field JK, Spandidos DA, Stell PM, Vaughan ED, Evan GI, Moore JP. Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma. Oncogene 1989; 4: 1463-8.
11. 11. Grover R, Ross DA, Wilson GD. C-myc oncoprotein: an independent prognostic marker for primary melanoma and its association with tumour antigenicity. Melanoma Research 1995; 5(S1): 17-18.
12. 12. Grover R, Ross DA, Sanders R, Wilson GD. C-myc oncoprotein, an independent prognostic marker for intermediate thickness primary melanoma. Plast Reconstr Surg: in press.
13. 13. Grover R, Ross DA, Wilson GD, Sanders R. Measurement of c-myc oncoprotein provides an independent prognostic marker for regional metastatic melanoma. Br J Plast Surg 1997; 50: 478-82.
14. 14. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin embedded pathological material using flow cytometry. J Histochem Cytochem 1983; 31: 1333-5.
15. 15. Kaplan EL, Meier P. Nonparametric estimation of incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
16. 16. Shumate CR, Carlson GW, Giacco GG, Guinee VF, Byers RM. The prognostic implications of location for scalp melanoma. Am J Surg 1991; 162: 315-9.
17. 17. Grover R, Grobbelaar AO, Hudson DA, Forder M, Wilson GD, Sanders R. The clinical significance of oncogene expression in subungual melanoma. Br J Plast Surg 1997; 50: 15-9.
18. 18. Grobbelaar AO, Grover R, Chana JS, Hudson DA, Wilson GD, Sanders R. The clinical significance of c-myc oncogene expression in subungual and plantar melanoma. Melanoma Res 1997; 7(S1): 6.
19. 19. Balch CM, Soong SJ, Shaw HM, Urist MM, McCarthy WH. An analysis of prognostic factors in 8,500 patients with cutaneous melanoma. In: Balch CM, Houghton AM, Milton GW, Sober AJ, Soong SJ, editors. Cutaneous Melanoma. 2nd ed. Philadelphia: Lippincott, 1992: 165-87.
20. 20. Littlewood TD, Evan GI. The role of myc oncogenes in cell growth and differentiation. Adv Dental Res 1990; 4: 69-79.
21. 21. Shlagbauer-Wadl H, Griffioen M, van Elsas A, et al. C-myc gene expression positively correlates with metastatic potential of human melanoma in SCID mice. Melanoma Res 1997; 7(S1): 6.